Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 4 studies | 29% ± 5% | |
goblet cell | 4 studies | 33% ± 12% | |
pancreatic A cell | 3 studies | 40% ± 24% | |
ciliated cell | 3 studies | 21% ± 5% | |
epithelial cell | 3 studies | 37% ± 15% | |
type II pneumocyte | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 3 studies | 37% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2150.71 | 226 / 226 | 98% | 48.54 | 399 / 406 |
pancreas | 100% | 1690.84 | 328 / 328 | 86% | 31.24 | 153 / 178 |
stomach | 76% | 1863.94 | 274 / 359 | 94% | 52.33 | 268 / 286 |
lung | 93% | 1074.89 | 537 / 578 | 51% | 22.20 | 590 / 1155 |
intestine | 43% | 302.75 | 413 / 966 | 94% | 57.33 | 496 / 527 |
thymus | 82% | 408.13 | 533 / 653 | 19% | 3.46 | 113 / 605 |
esophagus | 1% | 2.47 | 9 / 1445 | 45% | 20.39 | 83 / 183 |
ovary | 1% | 2.33 | 1 / 180 | 37% | 9.50 | 158 / 430 |
bladder | 0% | 0 | 0 / 21 | 29% | 14.80 | 148 / 504 |
uterus | 8% | 54.71 | 14 / 170 | 18% | 7.66 | 84 / 459 |
adrenal gland | 0% | 0 | 0 / 258 | 5% | 2.60 | 12 / 230 |
brain | 2% | 10.15 | 64 / 2642 | 1% | 0.34 | 9 / 705 |
prostate | 1% | 2.55 | 3 / 245 | 2% | 0.24 | 9 / 502 |
kidney | 0% | 0 | 0 / 89 | 2% | 0.29 | 22 / 901 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.22 | 1 / 45 |
skin | 0% | 0 | 0 / 1809 | 1% | 0.15 | 4 / 472 |
peripheral blood | 1% | 2.19 | 7 / 929 | 0% | 0 | 0 / 0 |
breast | 0% | 0.97 | 1 / 459 | 0% | 0.08 | 4 / 1118 |
spleen | 0% | 1.63 | 1 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.63 | 3 / 803 | 0% | 0 | 0 / 0 |
adipose | 0% | 1.44 | 4 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.18 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_2000543 | Biological process | positive regulation of gastrulation |
GO_0001708 | Biological process | cell fate specification |
GO_0000432 | Biological process | positive regulation of transcription from RNA polymerase II promoter by glucose |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090009 | Biological process | primitive streak formation |
GO_0008344 | Biological process | adult locomotory behavior |
GO_0061987 | Biological process | negative regulation of transcription from RNA polymerase II promoter by glucose |
GO_0071542 | Biological process | dopaminergic neuron differentiation |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0030193 | Biological process | regulation of blood coagulation |
GO_0040019 | Biological process | positive regulation of embryonic development |
GO_0070741 | Biological process | response to interleukin-6 |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0061178 | Biological process | regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0030154 | Biological process | cell differentiation |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_2000049 | Biological process | positive regulation of cell-cell adhesion mediated by cadherin |
GO_0031018 | Biological process | endocrine pancreas development |
GO_0033132 | Biological process | negative regulation of glucokinase activity |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0030054 | Cellular component | cell junction |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
Gene name | FOXA2 |
Protein name | Forkhead box A2 Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Transcription factor 3B) (TCF-3B) |
Synonyms | TCF3B hCG_22162 HNF3B |
Description | FUNCTION: Transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues. Is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites. Binds DNA with the consensus sequence 5'-[AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3' (By similarity). In embryonic development is required for notochord formation. Involved in the development of multiple endoderm-derived organ systems such as the liver, pancreas and lungs; FOXA1 and FOXA2 seem to have at least in part redundant roles. Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis; regulates the expression of genes important for glucose sensing in pancreatic beta-cells and glucose homeostasis. Involved in regulation of fat metabolism. Binds to fibrinogen beta promoter and is involved in IL6-induced fibrinogen beta transcriptional activation. . |
Accessions | ENST00000419308.7 [Q9Y261-2] Q9Y261 B0ZTD4 A0A2Z1D411 ENST00000377115.4 [Q9Y261-1] |